Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6490
    +0.0001 (+0.01%)
     

  • OIL

    82.82
    -0.54 (-0.65%)
     

  • GOLD

    2,337.10
    -5.00 (-0.21%)
     

  • Bitcoin AUD

    99,642.06
    -3,098.48 (-3.02%)
     

  • CMC Crypto 200

    1,401.26
    -22.84 (-1.60%)
     

  • AUD/EUR

    0.6070
    +0.0014 (+0.23%)
     

  • AUD/NZD

    1.0950
    +0.0020 (+0.18%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,460.90
    -10.57 (-0.06%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,365.59
    -138.10 (-0.36%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

iRhythm
·1-min read
iRhythm
iRhythm

SAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

iRhythm’s management is scheduled to present on Tuesday, January 10, 2023, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact:
Stephanie Zhadkevich
(919) 452-5430
stephanie.zhadkevich@irhythmtech.com

iRhythm Media Contact:
Morgan Mathis
(310) 528-6306
irhythm@highwirepr.com